本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEIJING, Dec. 11, 2024 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company, today announced that it will report its financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Tuesday, December 17, 2024. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management will hold an earnings conference call at 6:00 AM on Tuesday, December 17, 2024, U.S. Eastern Time (7:00 PM on Tuesday, December 17, 2024, Beijing Time/Hong Kong Time). Participants may access the call by dialing the following numbers: Main Line: International: 1-412-317-6061United States Toll Free: 1-888-317-6003Mainland China Toll Free: 4001-206115Hong Kong Toll Free: 800-963976Conference ID: 7464171 English Translation: International: 1-412-317-6061United States Toll Free: 1-888-317-6003Mainland China Toll Free: 4001-206115Hong Kong Toll Free: 800-963976Conference ID: 0402119 The replay of the conference call will be accessible through December 24, 2024 by dialing the following numbers: Main Line: International: 1-412-317-0088 United States Toll Free: +1-877-344-7529Access Code: 9229412 English Translation: International: 1-412-317-0088United States Toll Free: 1-877-344-7529Access Code: 4935588 A live and archived webcast of the conference call will also be available at the Company's investor relations website at http://ir.cmcm.com. About Cheetah Mobile Inc. Cheetah Mobile is a China-based IT company with a commitment to AI innovation. It has attracted hundreds of millions of users through an array of internet products and services on PCs and mobile devices. At the same time, it actively engages in the independent research and development of its AI technologies, including LLM technologies. Cheetah Mobile provides advertising services to advertisers worldwide, value-added services including the sale of premium membership to its users, multi-cloud management platform to companies globally, as well as service robots to international clients. Cheetah Mobile is also committed to leveraging its cutting-edge AI technologies, including LLM technologies, to empower its products and make the world smarter. It has been listed on the New York Stock Exchange since May 2014. For investor inquiries, please contact:Helen Jing ZhuCheetah Mobile Inc.Tel: +86 10 6292 7779Email: ir@cmcm.com
SHANGHAI, Nov. 27, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will hold investor calls on the data results from EVER001 Phase 1b/2a clinical study in primary membranous nephropathy. EVER001 is a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor, and Everest owns the global rights to develop EVER001 for the treatment of renal diseases. The English session of the conference call will be held at 9:00 AM on Dec. 4, 2024 Beijing Time (8:00 PM U.S. Eastern Time on Dec. 3, 2024) and the Mandarin session of the conference call will be held at 10:30 AM Beijing Time on the same day (9:30 PM U.S. Eastern Time on Dec. 3, 2024). The conference calls can be accessed by the following links: For English Session: Time: 9:00 AM Beijing Time, Wednesday, Dec. 4, 2024 (8:00 PM U.S. Eastern Time on Dec. 3, 2024) Pre-Registration Link: https://www.acecamptech.com/eventDetail/60510700 Webcast Link: https://www.acecamptech.com/meeting_live/70512679/774680?event_id=60510700 Alternatively, participants may dial in to the conference call using below dial-in information: United States: +1-646-2543594 (EN)Chinese Mainland: +86-10-58084166 (EN) +86-10-58084199 (CN)Hong Kong, China: +852-30051313 (EN) +852-30051355 (CN)United Kingdom: +44-12-1368-0466 (EN)International: +1-866-6363243 (EN)Password: 842080 For Mandarin Session: Time: 10:30 AM Beijing Time, Wednesday, Dec. 4, 2024 (9:30 PM U.S. Eastern Time on Dec. 3, 2024) Webcast Link: https://s.comein.cn/n3arj55s Alternatively, participants may dial into the conference call using below dial-in information: United States: +1-646-3578788 +1-408-7093255Chinese Mainland: 400-969-8928 400-806-3263Hong Kong, China: +852-301-83602Taiwan, China: +886-226563394 +886-277417882Singapore: +65-64075649 +65-66220840United Kingdom: +44-2070970018International: +86-2362737123Password: 377570 The replay of English session will be available shortly after the call and can be accessed by visiting the Company's website at http://www.everestmedicines.com. About EVER001 EVER001 (previously known as XNW1011) is a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor in development globally for the treatment of renal diseases. BTK is an essential component of the B-cell receptor signaling pathways that regulate the survival, activation, proliferation, and differentiation of B lymphocytes. Targeting BTK with small molecule inhibitors has been demonstrated to be an effective treatment option for B-cell lymphomas and autoimmune diseases. Based in part on results from a completed phase 1 study with healthy subjects conducted by SinoMab in China, EVER001 exhibited high selectivity, excellent pharmacokinetics properties, robust target engagement and a safety profile that supports continued clinical development. Under an exclusive licensing agreement with Evopoint Biosciences and SinoMab BioScience, Everest owns the global rights to develop, produce and commercialize EVER001 for the treatment of renal diseases. About Everest Medicines Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.
BEIJING, Nov. 25, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that management will participate in the following upcoming investor conferences in November 2024: Event: Huafu Securities 2024 Technology & Smart Manufacturing Strategy ConferenceDate: November 25, 2024Place: Shenzhen, ChinaOrganizer: Huafu Securities Event: NaaS 2024 Institutional Investor Virtual ConferenceDate: November 26, 2024Place: OnlineOrganizer: Caitong Securities Event: Tianfeng Securities 'Decisive Moment' 2025 Annual Strategy ConferenceDate: November 27, 2024Place: Shenzhen, ChinaOrganizer: Tianfeng Securities Connect with NaaS Management For more information or to schedule a one-on-one meeting with NaaS management, please contact your event representative or NaaS investor relations team via email at ir@enaas.com About NaaS Technology Inc. NaaS Technology Inc. is the first U.S. listed EV charging service company in China. The Company is a subsidiary of Newlinks Technology Limited, a leading energy digitalization group in China. The Company provides one-stop solutions to energy asset owners comprising charging services, energy solutions and new initiatives, supporting every stage of energy assets' lifecycle and facilitating energy transition. Safe Harbor Statement This press release contains statements of a forward-looking nature. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as "will," "expects," "believes," "anticipates," "intends," "estimates" and similar statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the Company and the industry. All information provided in this press release is as of the date hereof, and the Company undertakes no obligation to update any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NaaS' goals and strategies; its future business development, financial conditions and results of operations; its ability to continuously develop new technology, services and products and keep up with changes in the industries in which it operates; growth of China's EV charging industry and EV charging service industry and NaaS' future business development; demand for and market acceptance of NaaS' products and services; NaaS' ability to protect and enforce its intellectual property rights; NaaS' ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China trade war and its effect on NaaS' operation, fluctuations of the RMB exchange rate, and NaaS' ability to obtain adequate financing for its planned capital expenditure requirements; NaaS' relationships with end-users, customers, suppliers and other business partners; competition in the industry; relevant government policies and regulations related to the industry; and fluctuations in general economic and business conditions in China and globally. Further information regarding these and other risks is included in NaaS' filings with the SEC. For investor and media inquiries, please contact:Investor RelationsNaaS Technology Inc.E-mail: ir@enaas.comMedia inquiries:E-mail: pr@enaas.com
BEIJING, Nov. 20, 2024 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss third quarter 2024 results on Tuesday, November 26, 2024, at 8:00 a.m. EST. The earnings release and related investor deck will be available prior to the event in the "Quarterly Results" section under "Financials", while the live webcast will be available in the "Events" section under the "News & Events" header on the investor relations website at ir.chechegroup.com. The dial-in numbers for the conference call will be as follows: Participant (toll-free): 1-888-346-8982 Participant (international): 1-412-902-4272 Hong Kong LT: 852-301-84992 Hong Kong Toll Free: 800-905945 Mainland China Toll-Free: 852-301-84992 Please dial in 10 to 15 minutes before the scheduled start time and request Cheche's third quarter earnings call. The Company intends to make the webcast replay available for one year. About Cheche Group Inc. Established in 2014 and headquartered in Beijing, China, Cheche is a leading auto insurance technology platform with a nationwide network of around 108 branches licensed to distribute insurance policies across 25 provinces, autonomous regions, and municipalities in China. Capitalizing on its leading position in auto insurance transaction services, Cheche has evolved into a comprehensive, data-driven technology platform that offers a full suite of services and products for digital insurance transactions and insurance SaaS solutions in China. Learn more at https://www.chechegroup.com/en. Cheche Group Inc.: IR@chechegroup.com Crocker Coulsoncrocker.coulson@aummedia.org(646) 652-7185
NANJING, China, Nov. 20, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it plans to release its unaudited financial results for the third quarter ended September 30, 2024, before the market opens on December 5, 2024. Tuniu's management will hold an earnings conference call at 8:00 am U.S. Eastern Time on December 5, 2024 (9:00 pm Beijing/Hong Kong Time on December 5, 2024). Listeners may access the call by dialing the following numbers: US 1-888-346-8982 Hong Kong 852-301-84992 Mainland China 4001-201203 International 1-412-902-4272 Conference ID: Tuniu 3Q 2024 Earnings Conference Call A telephone replay will be available one hour after the end of the conference call through December 12, 2024. The dial-in details are as follows: US 1-877-344-7529 International 1-412-317-0088 Replay Access Code: 6264965 Additionally, a live and archived webcast of this conference call will be available at http://ir.tuniu.com/. About Tuniu Corporation Tuniu (Nasdaq:TOUR) is a leading online leisure travel company in China that offers integrated travel service with a large selection of packaged tours, including organized and self-guided tours, as well as travel-related services for leisure travelers through its website tuniu.com and mobile platform. Tuniu provides one-stop leisure travel solutions and a compelling customer experience through its online platform and offline service network, including a dedicated team of professional customer service representatives, 24/7 call centers, extensive networks of offline retail stores and self-operated local tour operators. For more information, please visit http://ir.tuniu.com.
BEIJING, Nov. 19, 2024 /PRNewswire/ -- Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the third quarter ended September 30, 2024, before U.S. markets open on Wednesday, December 4, 2024. Gaotu's management will hold an earnings conference call at 8:00 AM U.S. Eastern Time on Wednesday, December 4, 2024 (9:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-317-6061 United States: +1-888-317-6003 Hong Kong: 800-963-976 Mainland China: 400-120-6115 Passcode: 7597303 A telephone replay will be available two hours after the conclusion of the conference call through December 11, 2024. The dial-in details are as follows: International: +1-412-317-0088 United States: +1-877-344-7529 Passcode: 1398008 Additionally, a live and archived webcast of this conference call will be available at https://ir.gaotu.cn/home. About Gaotu Techedu Inc. Gaotu is a technology-driven education company and online large-class tutoring service provider in China. The Company offers learning services and educational contents & digitalized learning products. Gaotu adopts an online live large-class format to deliver its courses, which the Company believes is the most effective and scalable model to disseminate scarce high-quality teaching resources to aspiring students in China. Big data analytics permeates every aspect of the Company's business and facilitates the application of the latest technology to improve teaching delivery, student learning experience, and operational efficiency. For further information, please contact: Gaotu Techedu Inc.Investor RelationsE-mail: ir@gaotu.cn Christensen In ChinaMs. Vivian WangPhone: +852 2232 3978E-mail: gotu@christensencomms.com In the USMs. Linda BergkampPhone: +1-480-614-3004E-mail: linda.bergkamp@christensencomms.com
A12 藝術空間
Conference call announcements
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
